Oral GLP-1s rapidly expanding user base
US$ 20.21
hers glp-1 Weight Loss Care for Women, Built to Last Hers – GLP1 Match
Description
Dig Dis Sci (1989) 34(9):14119
Unlike existing GLP-1 therapies, which are peptide-based and require injections, orforglipron is a synthetic, non-peptide small molecule: orally bioavailable, once-daily, and independent of food or water intake
Satiety regulation (reduces appetite, aiding in weight loss)
Not all will qualify
Greater efficacy comes at the cost of greater side effect burden for some users
95% CI, 1.01-1.68)
